日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Drugmakers step up efforts for innovative product R&D

By ZHENG YIRAN | China Daily | Updated: 2020-06-30 09:29
Share
Share - WeChat
Visitors make inquiries at the stand of Bristol-Myers Squibb during the second China International Import Expo in Shanghai on Nov 9, 2019. [Photo/LYU LIANG FOR CHINA DAILY]

Favorable policies spur transformation as profit margins for generic drugs shrink

Pharmaceutical enterprises from home and abroad are stepping up efforts in innovative drug research and development as the domestic innovation environment constantly improves and profit margins for generic drugs gradually shrink, said industry experts.

Zhang Lichao, a senior researcher at Guosen Securities, said both domestic and international pharmaceutical firms in China are undergoing innovative transformation. They have stronger innovation momentum, and have been constantly expanding investment in R&D.

"With favorable policies for innovative drugs and reducing profits for generic drugs, innovation has become the only way for the development of high-quality pharmaceutical enterprises," Zhang said.

On June 11, United States-based biopharmaceutical giant Bristol-Myers Squibb unveiled a new corporate brand in China after its integration with US-based biotech company Celgene in November. BMS also announced its new strategy on the Chinese mainland, in which it plans to introduce up to 30 innovative products or indications to the market in the coming five years, many of which have potential to become first-in-class or best-in-class.

Chen Siyuan, president of BMS Chinese mainland and Hong Kong, said: "BMS has the world's most cutting-edge technology and R&D platform, with leading drug R&D capabilities in three major areas: chemistry, biologics and cell therapy. China is one of BMS' most important R&D, manufacturing, commercial and innovation centers. In the future, we will continue to focus on bringing innovative medicines to patients with cancer and other serious diseases."

In addition, the company is focused on cultivating a culture that encourages and recognizes innovation, and nurturing Chinese executives who have a deep understanding of the market with clear vision and global perspectives.

Domestic pharmaceutical firms are also taking action. Chongqing Pharscin Pharmaceutical Co Ltd announced that it would boost drug innovation, and has introduced a chief science officer, an innovative drug business unit, innovative drug labs and an innovative drug team.

Hangzhou, Zhejiang-province-based Yifan Pharmaceutical Co Ltd also launched a small module chemicals business unit to bring about small module innovative drugs.

A China Securities report showed that in the past five years, among the top-10 frequently used drug categories in Chinese hospitals, innovative drugs are taking an increasing percentage. One supportive policy behind this is the centralized generic drug procurement policy, which effectively lowered generic drug prices and decreased their profit margins. The medical insurance negotiation also sped up the inclusion of innovative drugs into medical insurance reimbursement, promoting the rapid increase of innovative drug penetration.

"These policies made pharmaceutical enterprises' pursuit of an innovation development path an inevitable trend. In the past two years, there was an obvious growth in R&D expenditure in the chemical and pharmaceutical sector," said the report.

In 2019, most of the leading chemical and pharmaceutical enterprises in China increased their R&D investment. The growth rate of R&D spending was higher than that of the sector's overall income, the China Securities report added.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 亚洲综合视频一区 | 狠狠色丁香婷婷久久综合考虑 | 色a综合 | 久操网址 | 激情综合激情五月 | 日韩一区二区在线观看视频 | 91在线播放网站 | 色房四播 | 五月天激情视频在线观看 | 国产欧美日韩精品a在线观看高清 | 午夜激情视频在线 | 日本www视频在线观看 | 99国产精品| 精品欧美高清一区二区免费 | 一区二区三区四区视频 | 色吊丝国产 | 免费看污又色又爽又黄视频 | 亚洲成人综合视频 | 香蕉成人国产精品免费看网站 | 国产成人短视频 | 免费看日韩A片无码视频软件 | 国产九色在线观看 | 久色激情 | 操操操日日日干干干 | 日韩福利视频一区 | 国产伦精品 | 欧美一区久久久 | 97av视频在线播放 | av网址在线播放 | 久草草视频在线观看免费高清 | 毛片在线不卡 | 国产精品成在线观看 | 日本精品久久久久久久久免费 | 欧美第一色 | 久久91综合国产91久久精品 | 免费一级片 | 精品国产一区二区三区久久久久久 | 奇米影音第四色 | 国产免费久久久久 | 欧美性狂猛bbbbbxxxxx | 亚洲精品一区 |